Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research published in the Journal of the Royal Society of Medicine suggests that empathic, positive messages from doctors may be of small benefit to patients suffering from pain, and improve their satisfaction about the care received.

Image courtesy of Shutterstock

The study, which combined data from 28 clinical trials involving over 6,000 patients, adds weight to the argument that patient outcomes can be improved when doctors enhance how they express empathy and create positive expectations of benefit.

The research team, from Oxford and Southampton universities in the UK, the Netherlands Institute for Health Services Research and Lithuania's Vilnius Gediminas Technical University, analysed a series of randomised clinical trials that looked at the effects of empathy or positive communication in healthcare consultations. These trials included data from consultations on a wide range of clinical conditions including pain, asthma, irritable bowel syndrome, osteoarthritis and recovery after surgery. The researchers also reviewed the effects of positive communication on quality of life and patient satisfaction, based on reports from patients in these trials.

Find out more (University of Oxford website)

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.